Vol. 13 No. 4 October 2006
A Case of Nodular Pseudoangiomatous Stromal Hyperplasia (PASH)
(PASH), which was first reported in 1986
type of benign proliferative lesion of the breast
stroma that is characterized by slit-like pseudovas-
cular spaces lined by endothelial-like spindle cells
in keloid fibrosis
by other benign and malignant breast lesions
although it is relatively rare for PASH to form a
palpable nodule. It is generally considered that
hormones, especially progesterone, can contri-
bute to the formation of PASH. We report here a
case in which breast enlargement and palpable
nodules including PASH shrank naturally, 18 mon-
ths after excisional biopsy.
1), is a
1, 2). PASH is often accompanied
A 36-year-old woman noticed slow, progressive
enlargement of her breasts (the right was larger
than the left) in 1990. After she detected soft nod-
ules in her right breast, she visited a local hospital
in March 2003. She underwent mammography
(MMG), ultrasonography (US), computed tomog-
raphy (CT), fine needle aspiration (FNA) and core
needle biopsy (CNB). FNA was not useful beca-
use of low cellularity, and CNB performed twice
demonstrated fibrotic proliferation, suggestive of
phyllodes tumors. She was subsequently referred
to our hospital. Seven nodules almost completely
occupied the right breast and peau-de-orange
changes of the skin were observed in the lower
inner portion. There were two nodules in the left
breast (Fig 1A, B). The nodules were firm, elastic
and well-defined. The right breast was obviously
larger than the left (Fig 1A). MMG showed no dis-
tinct tumor shadow because the breasts were
large and firm with some nodules and sufficient
pressure could not be applied. US demonstrated
seven tumors in the right and two in the left bre-
ast, which had regular borders for the most part
and showed low but partly heterogeneous echo-
Reprint requests to Kae Okoshi, Department of Surgery, Graduate
School of Medicine, Kyoto University, 54-Shogoin Kawara-cho,
Sakyo-ku, Kyoto 606-8507, Japan.
PASH, Pseudoangiomatous stromal hyperplasia; US, Ultrasono-
graphy; MMG, Mammography; FNA, Fine needle aspiration;
CNB, Core needle biopsy; CT, Computed tomography; MRI,
Magnetic resonance imaging; CD, Cluster of differentiation;
SMA, Smooth muscle actin
Received October 12, 2005; accepted May 8, 2006
Key words: Pseudoangiomatous stromal hyperplasia (PASH), Breast tumor, Myofibroblast
＊1Department of Surgery, Graduate School of Medicine, Kyoto University,
Pathology, and ＊4Department of Radiology, Otsu Red Cross Hospital, Japan.
＊2Department of Surgery,
＊1, Hiroki Ogawa
＊2, Hirofumi Suwa
＊2, Tatsuyoshi Saiga
＊3, and Hisato Kobayashi
Pseudoangiomatous stromal hyperplasia (PASH) of the breast is a common microscopic lesion that is
found at breast biopsy, and presents with proliferation of the stromal cells and slit-like pseudovascular
spaces with endothelial-like spindle cells. In contrast, nodular PASH is relatively rare. We report here a
case of nodular PASH with multiple palpable masses.
A 49-year-old woman who had experienced gradual enlargement of her breasts for 13 years noticed an
elastic but firm palpable mass in her breast. We were able to detect 7 masses in her right breast and 2 in
the left. Ultrasonography and mammography demonstrated nonspecific findings, and FNA and CNB did
not establish a diagnosis. An excisional biopsy was performed, and the pathological findings revealed nodu-
lar PASH. Eighteen months after the excisional biopsy, the size of the nodules and the whole breast had
decreased remarkably. While the possibility of a change in the hormonal background or the influence of
drugs was considered, we were not able to reach a single specific conclusion regarding the pathogenesis.
Breast Cancer 13:349-353, 2006.
genicity. In October 2003 an excisional biopsy was
performed on a mass in the upper inner quadrant
of her right breast to confirm the histological diag-
nosis (Fig 1B). The specimen was a well-circumsc-
ribed yellow-gray tumor, 3.8×3.0×1.9 cm in size.
She underwent MRI examination to investigate
the residual masses. The MRI showed several
high-intensity lesions on fat-suppressed T2-weigh-
ted images, and these lesions exhibited some sep-
tae with surrounding low-intensity signals (Fig 2).
Furthermore, the time-intensity curves showed
gradual increase, which suggested that the tum-
ors were benign.
In April 2005, the size of both breasts and the
remaining tumors had decreased remarkably, and
the two nodules in the left breast were no longer
Initially, fibrocystic disease of the mammary
glands with stromal hyperplasia was diagnosed.
The epithelial proliferation included cystic dilata-
tion of the ducts with apocrine metaplasia, blunt
duct adenosis, and duct papillomatosis (Fig 3A).
The diagnosis was determined by noting the pro-
liferative epithelial changes. After some discus-
sion, PASH was subsequently diagnosed. The vas-
cular endothelial-like spindle cells formed a ves-
sel-like slit in the stroma (Fig 3B) and immunohis-
tochemical staining for CD34, CD31, D2-40, smoo-
th muscle actin (SMA) and Factor Ⅷ supported
this diagnosis. The spindle cells were positive for
CD34 and, in part, SMA (Fig 3C, D) and negative
for CD31, D2-40 and FactorⅧ. The slits were the-
refore neither true lymph nor blood vessels and
were covered with myofibroblasts. The nuclei of
the ductal epithelial cells were immunopositive for
both estrogen and progesterone receptor, where-
as the stromal cells were negative.
(PASH), which was first reported by Vuitch et al.
in 1986, is a benign proliferative lesion of the bre-
ast stroma. Although the vascular endothelial-like
spindle cells form vessel-like slits in the stroma,
they are not true vessels covered with endothelia,
but rather vacant spaces bordered with myofibro-
blasts. PASH can be accompanied by other types
Okoshi K, et al
Nodular PASH of the Breast
Fig 1．A: There were seven masses in the right breast and
two in the left, which occupied almost the entire breast. The
right breast was obviously larger than the left and accompa-
nied by peau-de-orange change of the skin (arrowheads). B:
The gray circles in the schema demonstrated the distribution
of the palpable nodules. Excisional biopsy was performed on a
mass in the upper inner quadrant of the right breast (arrow).
Fig 2．MRI showed several high-intensity lesions on fat-sup-
pressed T2-weighted imaging. These lesions exhibited some
septae with surrounding low-intensity signals (arrowheads).
of breast tumors. Ibrahim et al.
PASH could be detected microscopically (at least
one lesion) in 23% of 200 cases of benign and mali-
gnant breast tumors. Morita et al.
PASH was associated with mastopathy (14.1%),
fibroadenoma (0.9%), and carcinoma (6.7%). On
the other hand, nodular PASH is relatively rare.
The histopathological differentiation between
PASH and a low-grade angiosarcoma is important.
In the case of PASH, there are no blood cells in
the slit-like spaces, and the lesions do not exhibit
any atypia or mitotic activity
Since the spindle cells that cover the vascular-
like-slit were immunopositive for CD34
they were also useful markers for making the his-
tological diagnosis. Furthermore, PASH exhibits
variable immunoreactivity for SMA
the spindle cells covering the vascular-like slits
were positive for CD34 and, in part, SMA. The
2, 3, 6)but immunonegative for Factor Ⅷ
5). In this study,
immunostaining pattern suggested that the spin-
dle cells consisted of a spectrum of cells, ranging
from relatively juvenile mesenchymal cells to
myofibroblasts. The term pseudo-angiomatous str-
omal hyperplasia expresses only the stromal form
of this lesion. It is often accompanied by hyperpla-
sia of the ducts and lobular epithelium, as well as
apocrine metaplasia and cyst formation
cases might not be diagnosed as PASH because
the ductal proliferative changes are apparently
more remarkable than those of the stroma. It is
necessary to differentiate PASH from other types
of benign breast tumors such as hamartomas,
fibroadenomas and phyllodes tumors
PASH occurs in premenopausal, perimenopos-
al or postmenopausal women who have taken hor-
mone replacement therapy
who have gynecomastia
terone receptor immunoreactivity is often posit-
2, 5, 7). Some
5, 8), and in 23.8% of men
3). Furthermore, proges-
5, 6, 8). Hence many authors have described PASH
Breast Cancer Vol. 13 No. 4 October 2006
Fig 3．A: Microscopy demonstrated that the lesion consisted of stromal hyperplasia, with epithelial proliferation,
papillomatous proliferation, and cystic dilatation of the ducts with apocrine metaplasia (arrowheads). B: The vascular
endothelial-like spindle cells (arrows) formed a vessel-like slit (arrowheads) in the stroma. C: Immunopositivity for
CD34 was evident all over the spindle cells covering the vessel-like slits. D: Immunopositivity forα -SMA was evident
in the smooth muscle of the true blood vessels (arrowheads) and partly in the spindle cells lining the pseudovascular
as being hormone-dependent; in other words,
PASH is hyperplasia of the stromal cells induced
by an excessive response to progesterone
this case the patient was perimenopausal when
she came to our hospital, however, on immunos-
taining neither estrogen nor progesterone recep-
tor was apparent in stromal cells. Thus, there was
only indirect evidence of a hormonal etiology in
Since she had been treated with loxoprofen
sodium, bucillamine and famotigine for articular
rheumatism, the possibility that the lesion was
drug-induced was raised. There has been one
case report of remarkable breast enlargement
while taking bucillamine
causes gynecomastia in men, and, rarely, lactation
and swelling of the breasts in women. In this case,
because the breasts had started to enlarge before
she was treated with the drugs in 2002, and the
lesions were asymmetric, the drugs might not
have been the main cause of the nodules but may
have exerted some influence on the growth of the
nodules. The patient stopped taking these drugs
in December 2003.
It is very difficult to diagnose of PASH by
imaging alone, with MMG, US and MRI
MMG, PASH exhibits no calcification, but usually
a totally or partially regular border, and some-
times an irregular one
in progressive asymmetrical breast tissues by
homogeneous, low to iso- and high-echoic solid
lesions to masses including a cystic structure.
Nevertheless, PASH typically presents with a reg-
ular border and a hypo-echoic lesion
have been a few case reports of MRI for PASH. In
one case report, PASH exhibited mainly interme-
diate signals with some low-intensity regions using
gadolinium-enhanced T1-weighted imaging, and
some lesions included high- and low-intensity are-
as covered with a low-intensity capsule
er case report, the findings from the time-intensity
curve demonstrated almost the same pattern as a
ful for examining the size, border and nature of
the tumor than the other imaging methods
Since the FNA findings for PASH are not spe-
case. Even when CNB is performed, it is neces-
sary to keep the possibility of PASH in mind
Although there has been a case report of
PASH that was treated by tamoxifen
12). Famotigine sometimes
7, 9-11). On
7, 9-11). PASH is often detected
13). On US, it exhibits variable findings, from
7, 9, 11). There
11). In anoth-
9), although the MRI was more use-
6), it is insufficient for diagnosis, as in this
14), some auth-
ors have recommended local widespread excisi-
bilateral mastectomy was performed for multiple
in which PASH became malignant. Moreover,
some authors have reported that when the find-
ings of imaging, US or MRI, and CNB are consis-
tent with PASH and were able to exclude malig-
nancy, resection is not necessary with close imag-
In this case, we found a total of 9 masses in
both breasts, one of which was diagnosed as
PASH. Since PASH often occurs in multiples, the
other 8 lesions could have been also PASH or oth-
er types of tumor. In order to definitively diagnose
all the tumors, we considered it necessary to res-
ect them all, because CNB was not sufficient for
definitive diagnosis. Since 7 nodules were distrib-
uted all over the right breast and occupied many
parts of the breast, we would have needed to per-
form right mastectomy to remove all the masses.
However, the findings from all the imaging proce-
dures indicated benign lesions, and the patient
preferred to continue with conservative manage-
ment. Thus we did not choose to perform such an
aggressive surgical procedure on her breasts and
decided to closely follow the lesions periodically.
Even though the remaining tumors shrank natu-
rally 18 months later, it may have been appropri-
ate to perform CNB on all residual nodules to con-
firm the diagnosis.
1, 5). Nevertheless, PASH sometimes recurs after
1, 5). Powel et al. reported a case in which
5). However, there have been no cases
We thank Dr. Paul Peter Rosen (New York-Presbyter-
ian Hospital Weill Cornell Medical Center), Dr. Goi
Sakamoto (The Cancer Institute of Japanese Foundation
for Cancer Research), Dr. Shu Ichihara and Dr. Suzuko
Moritani (National Hospital Organization Nagoya Medical
Center), and Dr. Yasuaki Nakashima (Kyoto University
Hospital) for their significant advice.
A summary of this report was presented at the 13th
annual meeting of the Japanese Breast Cancer Society in
Kurashiki in 2005.
1) Vuitch MF, Rosen PP, Erlandson RA: Pseudoan-
giomatous hyperplasia of mammary stroma. Hum
Pathol 17:185-191, 1986.
2) Ibrahim RE, Sciotto CG, Weidner N: Pseudoangioma-
tous hyperplasia of mammary stroma. Some observa-
tions regarding its clinicopathologic spectrum. Cancer
3) Milanezi MF, Saggioro FP, Zanati SG, Bazan R,
Okoshi K, et al
Nodular PASH of the Breast
Schmitt FC: Pseudoangiomatous hyperplasia of mam-
mary stroma associated with gynaecomastia. J Clin
Pathol 51:204-206, 1998.
4) Moriya T, Endoh M, Semba S: Pseudoangiomatous
stromal hyperplasia (PASH). Byori to Rinsyo 19:518-
520, 2001 (in Japanese).
5) Powell CM, Cranor ML, Rosen PP: Pseudoangioma-
tous stromal hyperplasia (PASH). A mammary stro-
mal tumor with myofibroblastic differentiation. Am J
Surg Pathol 19:270-277, 1995.
6) Lui PC, Law BK, Chu WC, Pang LM, Tse GM: Fine-
needle aspiration cytology of pseudoangiomatous
stromal hyperplasia of the breast. Diagn Cytopathol
7) Mercado CL, Naidrich SA, Hamele-Bena D, Fineberg
SA, Buchbinder SS: Pseudoangiomatous stromal
hyperplasia of the breast: sonographic features with
histopathologic correlation. Breast J 10:427-432, 2004.
8) Anderson C, Ricci A Jr, Pedersen CA, Cartun RW:
Immunocytochemical analysis of estrogen and prog-
esterone receptors in benign stromal lesions of the
breast. Evidence for hormonal etiology in pseudoan-
giomatous hyperplasia of mammary stroma. Am J
Surg Pathol 15:145-149, 1991.
9) Salvador R, Lirola JL, Dominguez R, Lopez M, Risu-
eno N: Pseudo-angiomatous stromal hyperplasia pre-
senting as a breast mass: imaging findings in three
patients. Breast 13:431-435, 2004.
10) Cyrlak D, Carpenter PM: Breast imaging case of
the day. Pseudoangiomatous stromal hyperplasia.
Radiographics 19:1086-1088, 1999.
11) Kirkpatrick UJ, Burrows C, Loughran CF: Imaging
appearances of pseudoangiomatous hyperplasia of
mammary stroma. Clin Radiol 55:576-578, 2000.
12) Sakai Y: Breast gigantism induced by Bucillamine.
Rheumatology 26:292-295, 2001 (in Japanese with Eng-
13) Piccoli CW, Feig SA, Palazzo JP: Developing asym-
metric breast tissue. Radiology 211:111-117, 1999.
14) Pruthi S, Reynolds C, Johnson RE, Gisvold JJ: Tamox-
ifen in the management of pseudoangiomatous stro-
mal hyperplasia. Breast J 7:434-439, 2001.
Breast Cancer Vol. 13 No. 4 October 2006